5 research outputs found
ΠΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΠΈΠ½ΡΠ΅Π³ΡΠ°ΡΠΈΠΈ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΡΡ ΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΠ΅ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ
Nowadays Information Technologies (IT) are taking more and more stable position in the process of work organization in various companies, and particularly among medical organizations. Present-day scientific society has already begun to research the topic of IT integration particularities into the Health organizations. Current article is focused on this issue. Our team has planned and provided a systematic review to understand which barriers can appear in different medical centers during implementation of the innovative IT into working process. The review has been fulfilled according to the designed protocol based on the actual recommendations of Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. In the course of the workflow we have explored 2050 articles complied with the requirements. As a result, 23 key publications have been chosen and analyzed in detail. After considering the list of issues and barriers associated with the IT Implementation into hospitals and medical centers have been highlighted and described. We have classified them to notional clusters depending on the reasons of their appearance as well. In addition our team has defined the list of practical recommendations following which the result of the IT integration will be improved, but the risk of a negative outcome in the future can be eliminated.ΠΠ° ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΌ ΡΡΠ°ΠΏΠ΅ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ (ΠΠ’) Π·Π°ΠΊΠΎΠ½ΠΎΠΌΠ΅ΡΠ½ΠΎ Π·Π°Π½ΠΈΠΌΠ°ΡΡ ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΡΡ ΠΏΠΎΠ·ΠΈΡΠΈΡ Π² ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΡΠ°Π±ΠΎΡΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΠΏΡΠ΅Π΄ΠΏΡΠΈΡΡΠΈΠΉ, Π² ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ. Π ΠΌΠΈΡΠΎΠ²ΠΎΠΌ Π½Π°ΡΡΠ½ΠΎΠΌ ΡΠΎΠΎΠ±ΡΠ΅ΡΡΠ²Π΅ Π²ΡΠ΅ Π±ΠΎΠ»ΡΡΠ΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΡ ΡΠ΄Π΅Π»ΡΠ΅ΡΡΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌ ΠΈΠ½ΡΠ΅Π³ΡΠ°ΡΠΈΠΈ ΠΠ’ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΡΡ ΡΡΠ΅Π΄Ρ, Π½Π° ΡΡΠΎΠΌ Π²ΠΎΠΏΡΠΎΡΠ΅ ΠΈ ΡΡΠΎΠΊΡΡΠΈΡΠΎΠ²Π°Π½ΠΎ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ Π°Π²ΡΠΎΡΠΎΠ² Π΄Π°Π½Π½ΠΎΠΉ ΡΡΠ°ΡΡΠΈ. ΠΠ°ΡΠΈΠΌ Π½Π°ΡΡΠ½ΡΠΌ ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΈΠ²ΠΎΠΌ Π±ΡΠ» ΡΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ ΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΎΠ±Π·ΠΎΡ, ΡΠ΅Π»ΡΡ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ Π±ΡΠ»ΠΎ ΠΏΠΎΠ»ΡΡΠΈΡΡ ΠΎΡΠ²Π΅Ρ Π½Π° ΠΏΠΎΡΡΠ°Π²Π»Π΅Π½Π½ΡΠΉ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΈΠΉ Π²ΠΎΠΏΡΠΎΡ: Ρ ΠΊΠ°ΠΊΠΈΠΌΠΈ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ°ΠΌΠΈ ΠΌΠΎΠ³ΡΡ ΡΡΠΎΠ»ΠΊΠ½ΡΡΡΡΡ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ Π² ΠΏΡΠΎΡΠ΅ΡΡΠ΅ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ Π½ΠΎΠ²ΡΡ
ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ? ΠΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠ΅ ΠΎΠ±Π·ΠΎΡΠ° ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ»ΠΎΡΡ ΠΏΠΎ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΠΎΠΌΡ ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌΠΈ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΡΠΌΠΈ Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Π Ρ
ΠΎΠ΄Π΅ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΡ
ΡΡΠ°ΠΏΠΎΠ² ΡΠ°Π±ΠΎΡΡ ΠΈΠ· 2050 ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Π½ΡΡ
ΡΡΠ°ΡΠ΅ΠΉ Π±ΡΠ»ΠΎ ΠΎΡΠΎΠ±ΡΠ°Π½ΠΎ 23 ΠΊΠ»ΡΡΠ΅Π²ΡΡ
ΡΡΠ°ΡΡΠΈ ΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΈΡ
Π΄Π΅ΡΠ°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·. Π ΠΈΡΠΎΠ³Π΅ Π±ΡΠ»ΠΈ Π²ΡΠ΄Π΅Π»Π΅Π½Ρ, ΠΊΠ»Π°ΡΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Ρ ΠΈ ΠΎΠΏΠΈΡΠ°Π½Ρ Π±Π°ΡΡΠ΅ΡΡ, ΠΏΡΠ΅ΠΏΡΡΡΡΠ²ΡΡΡΠΈΠ΅ ΡΡΠΏΠ΅ΡΠ½ΠΎΠΌΡ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ ΠΠ’ Π² ΡΡΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ. ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ, ΡΠΎΡΡΠ°Π²Π»Π΅Π½ ΡΠΏΠΈΡΠΎΠΊ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ, Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠ΅ ΠΊΠΎΡΠΎΡΡΡ
, Π²Π΅ΡΠΎΡΡΠ½ΠΎ, ΠΏΡΠΈΠ²Π΅Π΄Π΅Ρ ΠΊ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ ΡΠ½ΠΈΠ·ΠΈΡΡ ΡΠΈΡΠΊ Π½Π΅ΠΏΡΠΈΠ½ΡΡΠΈΡ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π² Π΄ΠΎΠ»Π³ΠΎΡΡΠΎΡΠ½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅
ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ: ΡΡΠΎ, Π³Π΄Π΅, ΠΊΠΎΠ³Π΄Π°?
Currently randomized clinical trials (RCTs) are a key stage in the development of new drugs. Despite the huge scale of the CT market, general awareness of the issue remains low and the society has formed a number of stereotypes and misconceptions about CTs. The presented review of Russian and foreign studies provides the information on the level of general awareness of clinical research in different countries, as well as among patients and practitioners. The conducted literature analysis demonstrates that awareness of clinical trials remains low both in society at large and among patients or in the professional community of practitioners. According to foreign studies, only 20β30% of respondents have heard anything about medical research while a relatively small percentage of respondents have more complete knowledge of RCTs. Among practitioners, only one in five is sufficiently informed about CTs while, according to different data, only about half fully realize what evidence-based medicine is and understand the importance of CTs as a source of reliable knowledge in everyday practice.ΠΠ° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ ΡΠ°Π½Π΄ΠΎΠΌΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²Π»ΡΡΡΡΡ ΠΊΠ»ΡΡΠ΅Π²ΡΠΌ ΡΡΠ°ΠΏΠΎΠΌ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ Π½ΠΎΠ²ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ². ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° ΠΎΠ³ΡΠΎΠΌΠ½ΡΠΉ ΠΌΠ°ΡΡΡΠ°Π± Π²ΡΠΏΠΎΠ»Π½ΡΠ΅ΠΌΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, ΠΎΡΠ²Π΅Π΄ΠΎΠΌΠ»Π΅Π½Π½ΠΎΡΡΡ ΠΎ Π΄Π°Π½Π½ΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ Π² ΡΠ΅Π»ΠΎΠΌ ΠΎΡΡΠ°Π΅ΡΡΡ Π½ΠΈΠ·ΠΊΠΎΠΉ, Π° Π² ΠΎΠ±ΡΠ΅ΡΡΠ²Π΅ ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ ΡΡΠ΄ ΡΡΠ΅ΡΠ΅ΠΎΡΠΈΠΏΠΎΠ² ΠΈ Π·Π°Π±Π»ΡΠΆΠ΄Π΅Π½ΠΈΠΉ ΠΎΠ± ΠΈΡ
ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ. ΠΠ°Π½Π½ΡΠΉ ΠΎΠ±Π·ΠΎΡ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΈ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
ΡΠ°Π±ΠΎΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΡΡΠΎΠ²Π΅Π½Ρ ΠΎΡΠ²Π΅Π΄ΠΎΠΌΠ»Π΅Π½Π½ΠΎΡΡΠΈ ΠΎ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
Π² ΡΠ°Π·Π½ΡΡ
ΡΡΡΠ°Π½Π°Ρ
Π² ΠΎΠ±ΡΠ΅ΡΡΠ²Π΅ Π² ΡΠ΅Π»ΠΎΠΌ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΡΠ΅Π΄ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈ ΠΏΡΠ°ΠΊΡΠΈΠΊΡΡΡΠΈΡ
Π²ΡΠ°ΡΠ΅ΠΉ Π² ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ. ΠΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΎΠΏΡΠΎΡΠ° Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
ΡΠ΅ΡΠΏΠΎΠ½Π΄Π΅Π½ΡΠΎΠ², ΡΠΎΠ»ΡΠΊΠΎ 20β30% ΠΈΠ· Π½ΠΈΡ
ΡΠ»ΡΡΠ°Π»ΠΈ ΡΡΠΎ-Π»ΠΈΠ±ΠΎ ΠΎ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
, ΠΏΡΠΈ ΡΡΠΎΠΌ Π±ΠΎΠ»Π΅Π΅ ΠΏΠΎΠ»Π½ΡΠΌΠΈ Π·Π½Π°Π½ΠΈΡΠΌΠΈ ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎ Π½Π΅Π±ΠΎΠ»ΡΡΠΎΠΉ ΠΏΡΠΎΡΠ΅Π½Ρ ΠΎΠΏΡΠΎΡΠ΅Π½Π½ΡΡ
. Π‘ΡΠ΅Π΄ΠΈ Π²ΡΠ°ΡΠ΅ΠΉ ΡΠΎΠ»ΡΠΊΠΎ ΠΊΠ°ΠΆΠ΄ΡΠΉ ΠΏΡΡΡΠΉ Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ ΠΎΡΠ²Π΅Π΄ΠΎΠΌΠ»Π΅Π½ ΠΎ Π½Π°ΡΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
, ΠΏΡΠΈ ΡΡΠΎΠΌ, ΠΏΠΎ ΡΠ°Π·Π½ΡΠΌ Π΄Π°Π½Π½ΡΠΌ, ΠΎΠΊΠΎΠ»ΠΎ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Ρ ΠΎΠΏΡΠΎΡΠ΅Π½Π½ΡΡ
Π² ΠΏΠΎΠ»Π½ΠΎΠΉ ΠΌΠ΅ΡΠ΅ ΠΏΠΎΠ½ΠΈΠΌΠ°ΡΡ ΠΈΡ
Π²Π°ΠΆΠ½ΠΎΡΡΡ ΠΊΠ°ΠΊ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠ° Π½Π°Π΄Π΅ΠΆΠ½ΡΡ
Π·Π½Π°Π½ΠΈΠΉ Π΄Π»Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠΈ ΠΈ ΠΈΠΌΠ΅ΡΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅, ΡΡΠΎ ΡΠ°ΠΊΠΎΠ΅ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½Π°Ρ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π°.
Development of innovative medicinal drugs in Russia: possibilities, barriers and practices. Evaluations and experiences of representatives of science, business and governmental organisations (Originele titel is Russisch)
Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π² Π ΠΎΡΡΠΈΠΈ: Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ, Π±Π°ΡΡΠ΅ΡΡ ΠΈ ΠΏΡΠ°ΠΊΡΠΈΠΊΠΈ. ΠΡΠ΅Π½ΠΊΠΈ ΠΈ ΠΎΠΏΡΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²ΠΈΡΠ΅Π»Π΅ΠΉ Π½Π°ΡΠΊΠΈ,Π±ΠΈΠ·Π½Π΅ΡΠ° ΠΈ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ[Development of innovative medicinal drugs in Russia: possibilities, barriers and practices. Evaluations and experiences of representatives of science,business and governmental organisations
Development of innovative medicinal drugs in Russia: possibilities, barriers and practices. Evaluations and experiences of representatives of science, business and governmental organisations (Originele titel is Russisch)
Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π² Π ΠΎΡΡΠΈΠΈ: Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ, Π±Π°ΡΡΠ΅ΡΡ ΠΈ ΠΏΡΠ°ΠΊΡΠΈΠΊΠΈ. ΠΡΠ΅Π½ΠΊΠΈ ΠΈ ΠΎΠΏΡΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²ΠΈΡΠ΅Π»Π΅ΠΉ Π½Π°ΡΠΊΠΈ,Π±ΠΈΠ·Π½Π΅ΡΠ° ΠΈ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ[Development of innovative medicinal drugs in Russia: possibilities, barriers and practices. Evaluations and experiences of representatives of science,business and governmental organisations